Tabebuia Impetiginosa Bark Extract

Tabebuia Impetiginosa Bark Extract and pregnancy

Not Recommended

• Absorbed into the body
• Fetal development

Tabebuia impetiginosa bark extract, also known as pau d'arco, contains bioactive compounds including lapachol and naphthoquinones that have been traditionally used for medicinal purposes. In cosmetics, it's valued for its antioxidant and antimicrobial properties. The primary concern during pregnancy stems from oral supplementation studies showing that lapachol and related compounds can cause uterine stimulation and have been associated with pregnancy complications in animal studies. While topical absorption is expected to be lower than oral intake, the compounds in pau d'arco are lipophilic and can penetrate skin. Due to the lack of safety studies specifically evaluating topical use during pregnancy and the known effects of its active constituents, most herbalists and naturopathic practitioners recommend avoiding pau d'arco products during pregnancy. There is no specific regulatory guidance from ACOG or FDA on topical pau d'arco use, but the general medical consensus is to avoid botanical extracts with known uterotonic or systemic effects during pregnancy unless safety has been specifically established. Given the traditional use of this herb for inducing menstruation and its pharmacologically active compounds, a precautionary approach is warranted.

Tabebuia Impetiginosa Bark Extract and breastfeeding

Caution Advised

• Passes into breast milk
• Infant exposure

Pau d'arco extract contains lipophilic compounds that could theoretically transfer into breast milk, though specific studies on topical use during lactation are not available. The main active constituents, lapachol and beta-lapachone, have been studied for their antimicrobial and immune-modulating properties. While there is no direct evidence of harm from topical application during breastfeeding, the lack of safety data combined with the bioactive nature of its compounds suggests caution. The concern is primarily theoretical: if absorbed systemically through skin, these compounds could potentially reach breast milk and expose the infant to pharmacologically active substances. Without specific guidance from pediatric or lactation organizations, many healthcare providers recommend using well-studied alternatives during breastfeeding. If you choose to use products containing this extract, consider applying it to areas away from the breast and ensuring thorough washing before breastfeeding.

Tabebuia Impetiginosa Bark Extract and postpartum

Safe to Use

For women who are not breastfeeding, pau d'arco extract can be used with minimal concern. Its antioxidant and anti-inflammatory properties may be beneficial for postpartum skin concerns. The main consideration is potential for allergic reaction or skin sensitivity, which can be tested with a patch test before regular use. Otherwise, topical application poses no specific postpartum concerns when breastfeeding is not a factor.

Tabebuia Impetiginosa Bark Extract and trying to conceive

Not Recommended

• Fertility effects
• Hormone disruptor

Since the active compounds in pau d'arco have been associated with uterine effects and the goal when trying to conceive is to create optimal conditions for implantation and early pregnancy, it's advisable to avoid this ingredient. The same precautions that apply during pregnancy should be considered when actively trying to conceive. Most fertility specialists recommend eliminating potentially problematic substances before conception occurs, as early pregnancy often goes undetected for several weeks. Given pau d'arco's traditional use as an emmenagogue (menstruation inducer) and lack of safety data, choosing alternative antioxidant ingredients is the more conservative approach.

Tabebuia Impetiginosa Bark Extract and PCOS

Safe to Use

Tabebuia impetiginosa bark extract has anti-inflammatory and antioxidant properties that may actually be beneficial for PCOS-related skin concerns. There is no evidence suggesting this botanical extract interferes with hormones or impacts PCOS symptoms negatively. The antimicrobial properties of pau d'arco extract may help with acne management, which is a common concern for women with PCOS. While it's not specifically studied for PCOS skin conditions, its general skin benefits and lack of hormonal activity make it a safe choice. As with any botanical ingredient, individual skin sensitivity should be considered, but there are no specific contraindications for use by women with PCOS.

Tabebuia Impetiginosa Bark Extract and general use

Safe to Use

• Common allergen

For the general population, pau d'arco extract is considered safe for topical use in cosmetic products. It provides antioxidant benefits and has antimicrobial properties that can support skin health. The primary concern is potential for allergic reaction in sensitive individuals or those with plant allergies. As with any botanical extract, a patch test is recommended before widespread use, especially for those with sensitive skin or known allergies to related plant families. The extract is permitted in cosmetics under both EU and US regulations. While comprehensive long-term safety studies are limited, traditional use and current cosmetic applications have not revealed significant safety concerns for topical use in healthy adults.

Everything else flagged for the same profiles

• Flagged in pregnancy
• Flagged in trying to conceive
• Flagged in breastfeeding

Related ingredients

Ingredients suggested in place of Tabebuia Impetiginosa Bark Extract, each one with its own page here.

• Resveratrol

Ingredients that raise the same concerns.

• Benzophenone-3Fertility effects, Fetal development, Hormone disruptor
• TriclosanFertility effects, Fetal development, Hormone disruptor
• ResorcinolFertility effects, Fetal development, Hormone disruptor
• TBHQFertility effects, Fetal development, Hormone disruptor
• Hydrastis Canadensis ExtractFertility effects, Fetal development, Hormone disruptor
• ParabensFertility effects, Fetal development, Hormone disruptor

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on 15 September 2026.